Executive Summary
The PTAB remand decision held that all 23 claims of Omni MedSci’s wearable pulse‑oximetry patent are unpatentable, applying 35 U.S.C. § 103 obviousness over multiple prior‑art references.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in WHOOP, Inc. vs Omni MedSci, Inc. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Capital One, National Association et al.vs--
Hulu and Capital One, together with Implicit, settled a dispute over a video‑streaming patent, prompting an unopposed motion to terminate the IPR.
Yangtze Memory Technologies Company, Ltd. et al.vsMicron Technology, Inc. et al.
The USPTO denied Yangtze Memory Technologies’ request for Director Review of the institution decisions in four IPRs, including the case involving patent 10,373,974. The denial leaves the original institution denials, which refused to institute the trials, in effect.
Google LLCvsValtrus Innovations Limited et al.
Google’s IPR against Valtrus’s 6,728,704 B2 patent was decided with all 23 challenged claims upheld. The Board found the prior‑art Bushee not anticipatory and rejected obviousness arguments over Voorhees, Tso, and Koppel.
Samsung Electronics Co., Ltd. et al.vsCM HK LIMITED
The PTAB denied Samsung’s request for Director Review of the institution decisions in two IPRs involving patent 11,698,687, leaving the institution decisions unchanged.
Samsung Electronics Co., Ltd et al.vsSecure Communication Technologies, LLC
Samsung and Secure Communication Technologies have settled their dispute over U.S. Patent 11,334,918 and filed a joint motion to terminate the pending IPR. The motion relies on 35 U.S.C. § 317 and cites Board policy favoring settlement before any merit decision.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.